CONCENTRATIONS AND CREDIT RISK (Details Narrative)	9 Months Ended
CONCENTRATIONS AND CREDIT RISK (Details Narrative)	Dec. 31, 2025	Dec. 31, 2024
One Customer [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	64.00%
Two Customers [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		64.00%
Two Customers [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		76.00%
Customer One [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		41.00%
Customer One [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		47.00%
Customer Two [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		23.00%
Customer Two [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		29.00%
One Customers [Member] \| Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	70.00%
Three Suppliers [Member] \| Purchases [Member] \| Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	75.00%	71.00%
Supplier One [Member] \| Purchases [Member] \| Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	39.00%	39.00%
Supplier Two [Member] \| Purchases [Member] \| Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	20.00%	16.00%
Supplier Three [Member] \| Purchases [Member] \| Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	16.00%	16.00%

ELITE PHARMACEUTICALS INC /NV/ 10-Q